“The World Congress on Parkinson’s Disease and Related Disorders, which took place in Milan from December 6th to 9th, concludes today.
Gondola Medical Technologies, the company that has developed the medical device for the treatment of freezing and motor symptoms in Parkinson’s disease, was present to discuss four new clinical studies. These studies were conducted by a team of researchers led by Prof. Fabrizio Stocchi from IRCCS San Raffaele Pisana in Rome and designed by Dr. Francesca Maria De Pandis from IRCCS San Raffaele Cassino, demonstrating the effectiveness of the AMPS therapy delivered by Gondola®.”